These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 606614)

  • 1. [Antibacterial activity of fosfomycin. II. Determination of minimal bactericidal concentration in association with other antibiotics].
    Grassi GG; Ferrara A; Navone A; Peona V; Sala P
    G Ital Chemioter; 1977; 23(2):87-94. PubMed ID: 606614
    [No Abstract]   [Full Text] [Related]  

  • 2. [Evaluation of the bactericidal activity of the combination of fosfomycin with other antibiotics by 2 different methods (checkboard and bactericidal curves)].
    Gialdroni Grassi G; Ferrara A; Peona V; Colombo ML
    G Ital Chemioter; 1983; 30(2-3):77-84. PubMed ID: 6376256
    [No Abstract]   [Full Text] [Related]  

  • 3. [Fosfomycin. I. Antimicrobial action in vitro].
    Carlone NA; Cuffini AM; Cattaneo O
    G Batteriol Virol Immunol; 1977; 70(1-6):100-7. PubMed ID: 614140
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Comparison between the in-vitro antibacterial activity of fosfomycin as determined using the M.I.C. and using the antibiogram].
    Renzini G; Oliva B
    G Ital Chemioter; 1977; 23(2):117-22. PubMed ID: 606610
    [No Abstract]   [Full Text] [Related]  

  • 5. Antibacterial activity of fosmidomycin on chromosomic and plasmid-determined fosfomycin-resistant strains.
    Mendez FJ; Alvarez AA; Mendoza MC; Hardisson C
    Chemioterapia; 1985 Apr; 4(2):170-5. PubMed ID: 4006006
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Fosfomycin, lysine-fosfomycin, arginine-fosfomycin: antibacterial activity in vitro].
    Angeretti A; Martinetto P; Valtz A
    G Batteriol Virol Immunol; 1980; 73(7-12):272-80. PubMed ID: 6796449
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Antibacterial activity of fosfomycin and of the association fosfomycin-rifampicin, upon gram negative bacteria (author's transl)].
    Zemelman R; González C; Mondaca MA
    Rev Med Chil; 1980 Dec; 108(12):1112-7. PubMed ID: 7302408
    [No Abstract]   [Full Text] [Related]  

  • 8. [Synergic action of the combination of fosfomycin and kanendomycin against gram-positive and gram-negative bacteria].
    Russo G; Toscano MA; Gismondo MR; Nicolosi V; Garaci E
    Ann Sclavo; 1980; 22(1):77-82. PubMed ID: 7247487
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [In vitro study of the cefamandole-fosfomycin combination against methicillin-resistant staphylococci].
    Fosse T; David MF; Duluc F; Darmusey D; Tamalet C; Toga B
    Pathol Biol (Paris); 1984 Jun; 32(5 Pt 2):528-31. PubMed ID: 6462742
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro activity of fosfomycin.
    Rodriguez A; Olay T; Oliver LE; Vicente MV
    G Ital Chemioter; 1977; 23(2):95-103. PubMed ID: 414954
    [No Abstract]   [Full Text] [Related]  

  • 11. [Epidemiological aspects relating to the determination of fosfomycin sensitivity: results of a study on 300 strains isolated in a hospital milieu in Turin].
    Vanini GC; Moiraghi Ruggenini A; Grassi R; Maury F; Giardini F
    G Batteriol Virol Immunol; 1979; 71(1-6):73-84. PubMed ID: 488578
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of subinhibitory concentrations of fosfomycin on bacteria.
    Lorian V; Atkinson B
    G Ital Chemioter; 1977; 23(2):65-74. PubMed ID: 342326
    [No Abstract]   [Full Text] [Related]  

  • 13. [In vitro antibacterial activity of fosfomycin].
    Giola L; Rizzu D; Zanetti S
    G Batteriol Virol Immunol; 1979; 71(1-6):34-40. PubMed ID: 385409
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Inhibition of growth in vitro of bacteria from the oral cavity using a combination of fosfomycin and ampicillin].
    Pase U; Tafuro A
    G Stomatol Ortognatodonzia; 1984; 3(3):358-60. PubMed ID: 6599001
    [No Abstract]   [Full Text] [Related]  

  • 15. [Practical meaning of the determination of the minimal inhibitory concentration (MIC) and the minimal bactericidal concentration (MBC) (author's transl)].
    Sanfilippo A
    Quad Sclavo Diagn; 1979 Jun; 15 Suppl 1():517-22. PubMed ID: 555528
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Sensitivity to fosfomycin of multiresistant serotype 012 Pseudomonas aeruginosa. Multicenter study].
    Dubrous P; Cavallo JD; Buisson Y
    Pathol Biol (Paris); 1997 Jun; 45(6):472-8. PubMed ID: 9309262
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Determination of the minimal inhibitory concentration and of the minimal bactericidal concentration. Bacteriostatic and bactericidal strength of serum].
    Gutmann L
    Soins Chir; 1985; (52-53):19-21. PubMed ID: 3851490
    [No Abstract]   [Full Text] [Related]  

  • 18. [In vitro antibacterial activity of a halogenated derivative of D-alanine].
    Viano I; Santiano M; Savoia D
    G Batteriol Virol Immunol; 1979; 72(1-6):134-42. PubMed ID: 121980
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Antibacterial effect of N-formimidoyl-thienamycin in combination with amikacin, cefoxitin and fosfomycin on K. pneumoniae and P. aeruginosa].
    Schröter G; Schrettenbrunner A
    Zentralbl Bakteriol Mikrobiol Hyg A Med Mikrobiol Infekt Parasitol; 1982 Dec; 253(3):355-7. PubMed ID: 6820589
    [No Abstract]   [Full Text] [Related]  

  • 20. In vitro activity of fosfomycin combined with rifampin, pefloxacin and imipenem against staphylococci: a study by the time-kill curve method.
    Quentin C; Saivin S; Lafferriere C; Noury P; Bebear C
    Drugs Exp Clin Res; 1987; 13(4):219-24. PubMed ID: 3476291
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.